Vimarsana
Biggest News Aggregation in the World

David Topkins News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Topkins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Topkins Today - Breaking & Trending Today

AI and Anti Competitive Behavior Price Fixing Algorithms - Vimarsana News

AI and Anti Competitive Behavior Price Fixing Algorithms

Dept of Justice Antitrust Division’s (first criminal antitrust case involving the use of AI  United States v. Topkins AI Algorithm to fix the prices of posters sold on Amazon The algorithm collected data to identify the lowest price in the market conspiring sellers inflated prices

AI and Antitrust – When Does an Algorithm Become an Agreement? | Robinson+Cole Data Privacy + Security Insider - Vimarsana News

AI and Antitrust – When Does an Algorithm Become an Agreement? | Robinson+Cole Data Privacy + Security Insider

This blog post is the first in a three-part series exploring the intersection between AI and antitrust.  The first blog post in this series discusses the U.S. Department...

Gotham City Online Scales Production with Epson Direct-to-Garment Printers - Vimarsana News

Gotham City Online Scales Production with Epson Direct-to-Garment Printers

/PRNewswire/ -- As one of the first online print-on-demand manufacturers, Gotham City Online needed a scalable printing solution to keep up with their growing...

Duvvuri Subbarao reviews IPR Bride & Competition Groom, by S. Chakravarthy - Vimarsana News

Duvvuri Subbarao reviews IPR Bride & Competition Groom, by S. Chakravarthy

Updated: January 24, 2021 10:23 IST A writer argues that IPR bestows market power but competition law ensures that such power is exercised within limits Share Article AAA A writer argues that IPR bestows market power but competition law ensures that such power is exercised within limits Over the last year, we have seen the world’s leading pharma companies racing ahead at a feverish pace to find a vaccine for COVID-19. Pharma laboratories typically face very heavy odds. Since only one in dozens of experiments succeeds, they load the costs of all failed trials on to the price of the one succe...